|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/70 | (2006.01) |
| A61K 39/09 | (2006.01) |
| (11) | Patento numeris | 3508579 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18211761.4 |
| Europos patento paraiškos padavimo data | 2013-11-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-07-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-06-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201261723408 P | 2012-11-07 | US |
| (72) |
WACKER, Michael , CH
KOWARIK, Michael , CH
WETTER, Michael , CH
FARIDMOAYER, Amirreza , CH
|
| (73) |
GlaxoSmithKline Biologicals SA ,
Rue de l'Institut, 89, 1330 Rixensart,
BE
|
| (54) | PRODUCTION OF RECOMBINANT VACCINE IN E. COLI BY ENZYMATIC CONJUGATION |
| PRODUCTION OF RECOMBINANT VACCINE IN E. COLI BY ENZYMATIC CONJUGATION |